Historically, abstinence-based recovery has sought to establish that recovering addicts abstain from all use of illicit substances including alcohol. This model of treatment was originally rooted in the Alcoholics Anonymous 12 Step Program which by design was intended to address alcohol addiction specifically. That program has been extremely popular and effective in helping alcohol dependent

Probuphine is a new drug recently developed and released by Braeburn Pharmaceuticals. The drug is FDA-approved and is a time-released version of buprenorphine (the active ingredient in Suboxone that staves off opioid withdrawal symtoms). Probuphine must be implanted beneath the patient’s skin (typically in the arm) where it gradually distributes medication for 6 months. The